MedTrace Logo

Characteristics of Sexual Dysfunction in Patients With Lung Cancer

NCT06018376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 553

Last updated 2026-02-06

Study results available
· View outcomes & findings →

Summary

The general objective of this observational study is identify and describe the type, frequency, and severity of sexual dysfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population. The recruitment will be carried out from July 2023 and will be carried out until December 2023, the analysis of the information will be carried out from January to March 2024.

Conditions

Interventions

DRUG

Systemic oncological treatment

Oncological systemic treatment for at least 3 months or being in oncological follow-up after having received systemic treatment for a minimum of 3 months

Sponsors & Collaborators

  • Fundación GECP

    lead OTHER

Principal Investigators

  • Aylen Vanessa Ospina Serrano, MD · Hospital Puerta del Hierro Investigator

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-13
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • Argentina
  • Colombia
  • Peru
  • Portugal
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018376 on ClinicalTrials.gov